Publication protocol
The evaluation of gene silencing of GAPDH was performed as reported previously15. Jurkat, THP-1, KG-1 or NK92 cells (6.0 × 105 cells) were seeded to 12 well plate and each carrier was added to the cells at siRNA doses of 1–30 nM. The RNAiMAX preparation was carried out following the manufacturer’s instructions. The RNAiMAX reagent (0.3 μl) was mixed with 1 nmol of siRNA. The cells were then incubated for 2 h at 37 °C in 0.5 ml of serum-free OPTI-MEM I. After a 2 h period of incubation, 0.5 ml of culture medium was added to the cells, followed by a further incubation for 22 h. After the incubation, the cells were collected and used for mRNA isolation using a RNeasy Mini Kit (QIAGEN, Hilden, Germany) according the manufacturer’s instructions. Briefly, the DNA contamination in the total RNA was eliminated by a DNase I treatment. The total RNA was then reverse-transcribed using a PrimeScript reverse transcription (RT) reagent Kit (Takara Bio Inc., Shiga, Japan) with oligo-dT primer. Quantitative polymerase chain reaction (PCR) was performed with a Mx3000 P QPCR System (Agilent Technologies, Santa Clara, CA) in 25 μl aliquots of reaction mixures containing cDNA, appropriate pairs of primers and THUNDERBIRD SYBR qPCR Mix (TOYOBO Co., Osaka, Japan). GAPDH level was calculated by the comparative CT method using beta actin as endogenous housekeeping genes. The following primer pairs were used: GAPDH: 5′-CCTCTGACTTCAACAGCGAC-3′ (forward); 5′-CGTTGTCATACCAGGAAATGAG-3′ (reverse); beta actin: 5′-CACTCTTCCAGCCTTCCTTC-3′ (forward); 5′-TACAGGTCTTTGCGCATGTC-3′ (reverse).
Full paper
Login or
join for free to view the full paper.
Videos
Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - Jurkat GAPDH Lipid using Silencer® GAPDH siRNA (human) from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.